Advanced Search


Study ID Status Title Patient Level Data
200293 Recruiting Drug Use Investigation of RELVAR® (vilanterol trifenatate and fluticasone furoate) for Asthma Patients
200294 Not yet recruiting Special Drug Use Investigation of RELVAR® for Asthma patients
200301 Completed An open-label study of inhaler device attributes investigating critical and overall errors, ease of use, and preference between a number of inhaler devices (ELLIPTA, TURBUHALER, HANDIHALER, BREEZHALER, MDI, and DISKUS/ACCUHALER) in adult subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on
200311 Recruiting Drug Use Investigation of ANORO ELLIPTA inhaler
200317 Active, Not Recruiting Belimumab 10mg/kg versus Placebo Post-hoc Analysis of Corticosteroid Use across 52 Weeks of Treament (BLISS-52 & BLISS-76 Meta-analysis)
200330 Completed An open-label study of inhaler device attributes investigating critical and overall errors, and ease of use and preference between a number of inhaler devices (ELLIPTA, DISKUS/ACCUHALER, TURBUHALER, and MDI) in adult subjects with asthma (Study 200330)
200338 Completed An Open-label Single-dose Pharmacokinetic Study of an Oral Formulation in Tablets Containing Eltrombopag 50 mg (Revolade, Glaxosmithkline Mexico, S.A. De C.V.) in Healthy Volunteers Under Fasting Conditions
200339 Completed An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector that Administers Belimumab Subcutaneously in Subjects with Systemic Lupus Erythematosus (SLE) Study Listed on
200341 Completed Evidence Synthesis and Mixed Treatment Comparisons for Evaluating Treatments for Asthma
200342 Completed Evidence Synthesis and Meta-Analysis Framework for Evaluating Treatments for COPD Patients
200347 Completed Indirect cost of illness study of moderate and severe asthma in Quebec
200367 Completed PGx6951: Analysis of influence of GLCCI1 variant rs37973 on inhaled corticosteroid response in COPD patients treated with fluticasone furoate in HZC112206 and HZC112207
200372 Completed A randomized, open-labelled non-drug interventional, cross-over, dry powder inhaler device preference study to compare “ease of use” of ELLIPTA (TM) inhaler with BREEZHALER (TM) inhaler in inhalation-device naïve Japanese volunteers aged 40 years or older
200374 Not yet recruiting Benefit of patient referral to epilepsy centers in Japan
200381 Completed Post-hoc analysis of Japanese phase II data on initial Parkinson’s disease motor dysfunctions (Study ID: 200381)
200382 Completed Cost-effectiveness of combined use of ropinirole controlled-release and L-dopa compared with L-dopa monotherapy in patients with Parkinson's disease
200385 Not yet recruiting Retrospective survey of lasting, treatment-free responders with ITP after cessation of drug therapy(RELIANT). Preliminary survey.
200395 Completed Investigation of clinical use of onabotulinumtoxinA for the treatment of upper and/or lower limb spasticity in poststroke patients with spastic hemiplegia
200398 Completed A Multi-centre, Single-blind, Parallel Group, Clinical Evaluation of the Efficacy and Safety of Clindamycin 1% / Benzoyl Peroxide 3% and Azelaic Acid 20% in the Topical Treatment of Mild to Moderate Acne Vulgaris Study Listed on
2003-Pediatric-Review Completed Paediatric-only clinical trials results of investigation of suicide attempts and “possibly suicide-related” events (2003 Paediatric Review).
200401 Completed A Phase 1, Single Dose, Crossover, Relative Bioavailability Study of a Dolutegravir Dispersible Tablet as Compared to a Dolutegravir Pediatric Granule Formulation and Effect of Different Types of Water on the Dispersible Tablet in Healthy Volunteers(200401)
200405 Completed An observational retrospective database analysis to estimate the risk of multiple sclerosis following vaccination with Arepanrix™ in Manitoba, Canada
200559 Recruiting Special drug use investigation of XYZAL® Syrup 0.05%
200561 Completed An open-label, randomized, single dose, three-way crossover, six sequence pilot study to evaluate the relative bioavailability of one amlodipine 10mg tablet and rosuvastatin 20mg tablet to two fixed dose combination tablet formulations of amlodipine (10mg) and rosuvastatin (20mg) in healthy adult male and female subjects under fasting conditions Study Listed on
200585 Recruiting Special Drug Use Investigation of ALLERMIST Nasal Spray in Pediatric Patients



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.